January 24–27, 2022
Hero background

Speakers

All speakers
James Carmichael

James Carmichael

View Public Profile

James Carmichael is a former Administrative Patent Judge on the Board of Patent Appeals and Interferences (now the Patent Trial and Appeal Board).  Jim was employed by the U.S. Patent and Trademark Office (PTO) for eight years, including working in the electrical and computer division of the Board as an Examiner-in-Chief.  Currently he represents inventors and patent challengers before the PTO in patent prosecution and inter partes review proceedings.  Jim regularly serves as an expert witness on PTO prosecution and post-grant procedures.

Before becoming a Judge, Jim served for five years as an Associate Solicitor of the PTO.  In that capacity, he represented the agency in federal court litigation and argued more than thirty cases at the U.S. Court of Appeals for the Federal Circuit.  The cases Jim handled included patentability and reexamination.  He was also Coordinator of attorney discipline proceedings.  Jim helped develop PTO procedures relating to the duty of disclosure as well as post-grant proceedings.

Jim graduated from Yale University in 1984, and from University of Wisconsin Law School in 1987 with honors.  During law school, he served as an Associate Editor of the Wisconsin Law Review.

Jim is a registered patent attorney and admitted to the bar in Washington, D.C. and California.

Sessions with James Carmichael

03:00 PM EST
January 24, 2022

The PTAB as the First Hurdle to Patent Monetization: How Patent Owners and Litigation Financers Deal with this Omnipresent Threat

How are patents being valued in the current market? What assertion strategies should Patent Owners consider going forward? Hear from the market players how licensees are being secured and negotiated in the shadow of the PTAB threat.

James Carmichael James Carmichael
Joshua Harris
Sean Thompson
Sarah Tsou

03:00 PM EST
January 25, 2022

But Wait!… There’s More. The Resurgence of Reexamination

AIA trials were designed to replace patent reexamination. So why are reexamination filings on the uptick? And what can patent owners gain from patent reissue and reexamination that may help stave off future PTAB attacks, or otherwise rehabilitate a vulnerable portfolio?

James Carmichael James Carmichael
Greg Gardella
David Ruschke